维普期刊资源整合服务平台（V6.5）

99篇 您的检索式：作者名="Navaneethan SD"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Meta - analysis : erythro- poiesis -stimulating agents in patients with chronic kidney disease显示文摘	Palmer SC Navaneethan SD Craig JC	2010	Ann Intern Med2010，153，1：	1
2	Effects of statins in patients with chronic kidney disease:metaanalysis and meta regression of randomised controlled trials显示文摘	Strippoli GF Navaneethan SD Johnson DW et el		0，，：	1
3	肾阻力指数和慢性肾脏病患者死亡率的关系显示文摘通过多普勒超声测量的肾阻力指数(renalresis—tiveindex,RRI)与高血压、糖尿病、老年患者心血管事件及死亡率相关。研究人员对高RRI(≥0.70)的影响因素,及其与无。肾动脉狭窄的肾脏病患者死亡率间的相关性进行评估。	Toledo C Thomas G Schold JD Arrigain S Gornik HL Nally JV Navaneethan SD 刘莉叶鹏	2015	中华高血压杂志2015，23，6：	1
4	Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery显示文摘	Navaneethan SD Kelly KR Sabbagh F	2010	Obes Surg2010，20，：	1
5	Aldosterone antagonists for preventing the progression of chronic kidney disease:a systematic review and meta-analysis显示文摘	Navaneethan SD Nigwekar SU Sehgal AR	2009	Clin J Am Soc Nephrol2009，4，3：	1
6	Serum bicar-bonate and mortality in stage 3 and stage 4 chronic kidney dis-ease 显示文摘	Navaneethan SD Schold JD Arrigain S	2011	Clin J Am Soc Nephrol2011，6，10：	1
7	Effects of statins in patients with chronic kidney disease:metaanalysis and meta-regression of randomized controlled trials显示文摘	Strippoli GF Navaneethan SD Johnson DW	2008	BMJ2008，336，：	1
8	HMG CoA reductase inhibitors(statins) for people with chronic kidney disease not requiring dialysis显示文摘	Navaneethan SD Pansini F Perkovic V		0，，：	1
9	Associations of serum uric acidwith cardiovascular events and mortality in moderate chronickidney disease 显示文摘	Navaneethan SD Beddhu S	2009	Nephrol Dial Transplant2009，24，：	1
10	HMG CoA redue-tase inhibitors (statins) for people with chronic kidney disease not requiring dialysis显示文摘	Palmer StY Navaneethan SD Craig JC	2015	Sao Paulo Med J2015，133，6：	1
11	Implications of the CKD-EPI GFR estimation equation in clinical practice显示文摘	Schold JD Navaneethan SD Jolly SE		0，，：	1
12	Atrial natriuretic peptide for management of acute kidney injury:a systematic review and meta-analysis显示文摘	Nigwekar SU Navaneethan SD Parikh CR		0，，02：	1
13	Haemoglobin and haematocrit target for the anaemia of chronic kidney disease 显示文摘	Strippoli GFM Navaneethan SD Craig JC	2006	Cochr Data Syst Rev2006，18，4：	1
14	Phosphatebinders for preventing and treating bone disease inchronic kidney disease patients显示文摘	Navaneethan SD Palmer SC Vecchio M	2011	Cochrane Databasesust Rer2011，，00：	1
15	A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease显示文摘	Navaneethan SD Aloudat S Singh S	2008	BMC Nephrol2008，9，3：	1
16	Benefitsand harms of phosphate binders in CKD: a systematic re-view of randomized controlled trials显示文摘	Navaneethan SD Palmer SC Craig JC	2009	Am J kidneydis2009，54，4：	1
17	Haemoglobin and haematocrit target for the anaemia of chronic kidney dis- ease显示文摘	Strippoli GFM Navaneethan SD Craig JC	2006	Cochrane Database Syst Rev2006，18，00：	1
18	Haemo- globin and haematocrit targets for the anaemia of chronic kidney disease显示文摘	Strippoli GFM Navaneethan SD Craig JC	2006	Cochrane Database Syst Rev2006，4，：	1
19	Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials 显示文摘	Navaneethan SD Pansini F Strippoli GF	2006	PLoS Med2006，3，：	1
20	HMG CoA reductase inhibitors (statins) for dialysis patients 显示文摘	Navaneethan SD Shrivastava R	2004	Cochrane Data base Syst Rev2004，4，00：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示